# Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk

> **NCT01213212** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 73 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **OTHER:** Caloric restriction
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01213212
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2013-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213212, "Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01213212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*